Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.15 - Poster Session 1 - Thymoma

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 9
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.15-002 - Results and Prognostic Features of Recurrent Thymoma

      09:30 - 09:30  |  Author(s): C. Xu

      • Abstract

      Loading...

  • +

    P2.15 - Poster Session 2 - Thymoma

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 8
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.15-002 - Patterns and Predictors of Recurrence after radical resection of Thymoma

      09:30 - 09:30  |  Author(s): C. Xu

      • Abstract

      Loading...

  • +

    O15 - NSCLC - Chemotherapy II

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:G. Richardson
    • Coordinates: 10/29/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1
    • +

      O15.07 - Final results of CTONG 0806: a phase II trial comparing pemetrexed with gefitinib as second-line treatment of advanced non-squamous NSCLC patients with wild-type EGFR

      11:35 - 11:45  |  Author(s): Q. Zhou

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.11 - Poster Session 3 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.11-005 - Randomized, open-label, multi-center study of Gefitinib dose-escalation (500mg/d versus 250mg/d) in advanced NSCLC patient achieved Stable Disease (SD) after one-month Gefitinib treatment

      09:30 - 09:30  |  Author(s): L. Zhang

      • Abstract

      Loading...